Does EMAPALUMAB-LZSG Cause Multiple organ dysfunction syndrome? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Multiple organ dysfunction syndrome have been filed in association with EMAPALUMAB-LZSG. This represents 3.8% of all adverse event reports for EMAPALUMAB-LZSG.
5
Reports of Multiple organ dysfunction syndrome with EMAPALUMAB-LZSG
3.8%
of all EMAPALUMAB-LZSG reports
4
Deaths
2
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From EMAPALUMAB-LZSG?
Of the 5 reports, 4 (80.0%) resulted in death, 2 (40.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMAPALUMAB-LZSG. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EMAPALUMAB-LZSG Cause?
Off label use (51)
Septic shock (19)
Haemophagocytic lymphohistiocytosis (17)
Condition aggravated (16)
Death (13)
Drug ineffective (11)
Pyrexia (8)
Gastrointestinal haemorrhage (7)
Respiratory failure (6)
Seizure (6)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which EMAPALUMAB-LZSG Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
EMAPALUMAB-LZSG vs EMEND
EMAPALUMAB-LZSG vs EMICIZUMAB
EMAPALUMAB-LZSG vs EMICIZUMAB-KXWH
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\LINAGLIPTIN